论文部分内容阅读
目的:评价分析小剂量氢化可的松治疗脓毒性休克的临床疗效。方法:基于住院号奇偶性将96例脓毒性休克患者划分为实验组和对照组,对照组接受常规治疗,实验组在对照组治疗基础上添加小剂量氢化可的松进行治疗,对比分析两组各项临床指标。结果:实验组在各时间点上的治疗改善情况明显优于对照组(P<0.05),结论:对于脓毒性休克患者而言,小剂量氢化可的松具有显著的临床效果,能够有效改善炎症症状,增强预后,有利于原发病的治疗,临床应用价值高。
Objective: To evaluate the clinical efficacy of low-dose hydrocortisone in the treatment of septic shock. Methods: 96 patients with septic shock were divided into experimental group and control group based on inpatient parity. The control group received routine treatment. The experimental group was treated with low-dose hydrocortisone on the basis of the control group. The two groups were compared The clinical indicators. Results: The improvement of the experimental group at each time point was significantly better than that of the control group (P <0.05). Conclusion: Small doses of hydrocortisone have significant clinical effect in patients with septic shock and can effectively improve the inflammation Symptoms, enhance the prognosis, is conducive to the treatment of primary disease, clinical application of high value.